Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,992	2,819	2,067	2,332	2,296	1,488
Other Revenue	192.02	138.84	47.17	108.67	67.67	9.49
Revenue	3,184	2,958	2,114	2,441	2,363	1,497
Revenue Growth (YoY)	25.96%	39.91%	-13.39%	3.28%	57.86%	-21.87%
Cost of Revenue	2,267	2,121	1,535	1,612	1,526	808.77
Gross Profit	917.58	836.44	579.23	829.2	837.21	688.42
Selling, General & Admin	229.99	222	221.61	232.28	175.11	143.25
Research & Development	256.48	233.34	189.13	187.71	133.53	84.3
Other Operating Expenses	22.73	13.83	9.21	-4.09	22.94	10.45
Operating Expenses	514.86	472.51	413.68	422.59	337.95	241.23
Operating Income	402.72	363.93	165.55	406.61	499.25	447.19
Interest Expense	-19.9	-27.43	-32.17	-20.01	-16.29	-3.86
Interest & Investment Income	183.62	160.75	219.77	236.78	229.61	52.18
Earnings From Equity Investments	-8.95	-8.95	-7.82	-3.71	-	-
Currency Exchange Gain (Loss)	18.51	36.73	29.59	82.97	-14.14	-18.26
Other Non Operating Income (Expenses)	-5.87	-6.04	-5.7	-4.61	-0.59	-0.32
EBT Excluding Unusual Items	570.13	518.99	369.22	698.03	697.84	476.93
Gain (Loss) on Sale of Investments	0.04	-	-	-	-	9.15
Gain (Loss) on Sale of Assets	5.61	0.42	-0.01	0.07	-	-
Asset Writedown	-0.06	-0.05	-0.26	-0.02	-0.06	-1.15
Other Unusual Items	33.53	28.66	79.97	-2.09	26.66	35.85
Pretax Income	609.26	548.02	448.92	695.99	724.45	520.79
Income Tax Expense	94.59	73.43	40.39	83.34	90.94	63.45
Earnings From Continuing Operations	514.67	474.59	408.54	612.65	633.51	457.34
Minority Interest in Earnings	35.51	14.37	-42.01	-59.39	-38.79	0.33
Net Income	550.18	488.96	366.52	553.27	594.72	457.67
Net Income to Common	550.18	488.96	366.52	553.27	594.72	457.67
Net Income Growth	47.85%	33.41%	-33.75%	-6.97%	29.94%	-4.43%
Shares Outstanding (Basic)	616	582	582	582	583	543
Shares Outstanding (Diluted)	616	582	582	582	583	543
Shares Change (YoY)	5.93%	0.05%	-0.10%	-0.11%	7.38%	6.91%
EPS (Basic)	0.89	0.84	0.63	0.95	1.02	0.84
EPS (Diluted)	0.89	0.84	0.63	0.95	1.02	0.84
EPS Growth	39.58%	33.33%	-33.68%	-6.86%	21.01%	-10.61%
Free Cash Flow	87.91	-22.38	-1,000	-3,395	-880.49	-248.15
Free Cash Flow Per Share	0.14	-0.04	-1.72	-5.83	-1.51	-0.46
Dividend Per Share	0.400	0.400	0.190	0.180	0.321	0.571
Dividend Growth	110.53%	110.53%	5.56%	-43.99%	-43.75%	-
Gross Margin	28.82%	28.28%	27.40%	33.97%	35.42%	45.98%
Operating Margin	12.65%	12.30%	7.83%	16.66%	21.12%	29.87%
Profit Margin	17.28%	16.53%	17.34%	22.66%	25.16%	30.57%
Free Cash Flow Margin	2.76%	-0.76%	-47.32%	-139.06%	-37.25%	-16.57%
EBITDA	713.88	679.85	451.26	671.73	667.79	565.51
EBITDA Margin	22.42%	22.98%	21.34%	27.52%	28.25%	37.77%
D&A For EBITDA	311.16	315.92	285.72	265.12	168.54	118.32
EBIT	402.72	363.93	165.55	406.61	499.25	447.19
EBIT Margin	12.65%	12.30%	7.83%	16.66%	21.12%	29.87%
Effective Tax Rate	15.53%	13.40%	9.00%	11.97%	12.55%	12.18%
Revenue as Reported	3,184	2,958	2,114	2,441	2,363	1,497

Source: S&P Global Market Intelligence. Standard template. Financial Sources.